Gene · 4920
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Irisin-regulated lncRNAs and their potential regulatory functions in chondrogenic differentiation of human mesenchymal stem cells. | Open Med (Wars) | 2024 | 39588384 | PubTator, text mining | PubMed |
| Improved Prediction of Ligand-Protein Binding Affinities by Meta-modeling. | J Chem Inf Model | 2024 | 39576762 | PubTator, text mining | PubMed |
| Twofold Expression of Receptor Tyrosine Kinase 2 (ROR2) in Giant Cell Tumors of Bone: Outcome of a Case‒Control Study. | Indian J Surg Oncol | 2024 | 39555360 | PubTator, text mining | PubMed |
| Correction to "WNT1/ROR2 Pathway Enhances the Triple-Negative Breast Cancer Invasion, Migration, and Epithelial-Mesenchymal Transition". | J Biochem Mol Toxicol | 2024 | 39503185 | PubTator, text mining | PubMed |
| Ror2 signaling regulated by differential Wnt proteins determines pathological fate of muscle mesenchymal progenitors. | Cell Death Dis | 2024 | 39468010 | PubTator, text mining | PubMed |
| WNT1/ROR2 pathway enhances the Triple-Negative breast cancer invasion, migration, and Epithelial-Mesenchymal transition. | J Biochem Mol Toxicol | 2024 | 39428718 | PubTator, text mining | PubMed |
| Novel biomarkers and drug correlations of non-canonical WNT signaling in prostate and breast cancer. | Discov Oncol | 2024 | 39347881 | PubTator, text mining | PubMed |
| Tetrandrine ameliorated atherosclerosis in vitamin D3/high cholesterol diet-challenged rats via modulation of miR-34a and Wnt5a/Ror2/ABCA1/NF-kB trajectory. | Sci Rep | 2024 | 39266573 | PubTator, text mining | PubMed |
| The rules of multiplayer cooperation in networks of communities. | PLoS Comput Biol | 2024 | 39159235 | PubTator, text mining | PubMed |
| ROR2 promotes cell cycle progression and cell proliferation through the PI3K/AKT signaling pathway in gastric cancer. | Mol Carcinog | 2024 | 39150155 | PubTator, text mining | PubMed |
| Down-regulation of PCBP2 suppresses the invasion and migration of trophoblasts via the WNT5A/ROR2 pathway in preeclampsia†. | Biol Reprod | 2024 | 39115369 | PubTator, text mining | PubMed |
| Wnt-5a-Receptor Tyrosine Kinase-Like Orphan Receptor 2 Signaling Provokes Metastatic Colonization and Angiogenesis in Renal Cell Carcinoma, and Prunetin Supresses the Axis Activation. | Am J Pathol | 2024 | 39069169 | PubTator, text mining | PubMed |
| ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma. | Cancer Discov | 2024 | 38975886 | PubTator, text mining | PubMed |
| ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling. | Oncol Res | 2024 | 38948021 | PubTator, text mining | PubMed |
| Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. | Mol Cancer Res | 2024 | 38912907 | PubTator, text mining | PubMed |
| Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling. | Elife | 2024 | 38780011 | PubTator, text mining | PubMed |
| Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations. | J Transl Med | 2024 | 38750573 | PubTator, text mining | PubMed |
| [Genetic analysis of a Chinese pedigree affected with Brachydactyly type B1 due to a novel variant of ROR2 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 38684301 | PubTator, text mining | PubMed |
| Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations. | Stem Cell Rev Rep | 2024 | 38639829 | PubTator, text mining | PubMed |
| miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression. | Cancer Gene Ther | 2024 | 38632356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4920/papers?page=4